These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30257713)

  • 21. Mutations in GMPPB Presenting with Pseudometabolic Myopathy.
    Panicucci C; Fiorillo C; Moro F; Astrea G; Brisca G; Trucco F; Pedemonte M; Lanteri P; Sciarretta L; Minetti C; Santorelli FM; Bruno C
    JIMD Rep; 2018; 38():23-31. PubMed ID: 28456886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.
    Polavarapu K; Mathur A; Joshi A; Nashi S; Preethish-Kumar V; Bardhan M; Sharma P; Parveen S; Seth M; Vengalil S; Chawla T; Shingavi L; Shamim U; Nayak S; Vivekanand A; Töpf A; Roos A; Horvath R; Lochmüller H; Nandeesh B; Arunachal G; Nalini A; Faruq M
    Neurogenetics; 2021 Oct; 22(4):271-285. PubMed ID: 34333724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.
    Puckett RL; Moore SA; Winder TL; Willer T; Romansky SG; Covault KK; Campbell KP; Abdenur JE
    Neuromuscul Disord; 2009 May; 19(5):352-6. PubMed ID: 19342235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations.
    Raphael AR; Couthouis J; Sakamuri S; Siskind C; Vogel H; Day JW; Gitler AD
    Brain Res; 2014 Aug; 1575():66-71. PubMed ID: 24780531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.
    Johnson K; Bertoli M; Phillips L; Töpf A; Van den Bergh P; Vissing J; Witting N; Nafissi S; Jamal-Omidi S; Łusakowska A; Kostera-Pruszczyk A; Potulska-Chromik A; Deconinck N; Wallgren-Pettersson C; Strang-Karlsson S; Colomer J; Claeys KG; De Ridder W; Baets J; von der Hagen M; Fernández-Torrón R; Zulaica Ijurco M; Espinal Valencia JB; Hahn A; Durmus H; Willis T; Xu L; Valkanas E; Mullen TE; Lek M; MacArthur DG; Straub V
    Skelet Muscle; 2018 Jul; 8(1):23. PubMed ID: 30060766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
    Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
    J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
    Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C
    Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan.
    Liang WC; Hayashi YK; Ogawa M; Wang CH; Huang WT; Nishino I; Jong YJ
    Neuromuscul Disord; 2013 Aug; 23(8):675-81. PubMed ID: 23800702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
    Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
    Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid therapy in an alpha-dystroglycanopathy due to GMPPB gene mutations: A case report.
    Fecarotta S; Gragnaniello V; Della Casa R; Romano A; Raiano E; Torella A; Savarese M; Nigro V; Strisciuglio P; Andria G; Parenti G
    Neuromuscul Disord; 2018 Nov; 28(11):956-960. PubMed ID: 30126629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the Phenotype of B3GALNT2-Related Disorders.
    D'haenens E; Vergult S; Menten B; Dheedene A; Kooy RF; Callewaert B
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy.
    Van den Bergh PYK; Sznajer Y; Van Parys V; van Tol W; Wevers RA; Lefeber DJ; Xu L; Lek M; MacArthur DG; Johnson K; Phillips L; Töpf A; Straub V
    Neuromuscul Disord; 2017 Nov; 27(11):1043-1046. PubMed ID: 28803818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.
    Godfrey C; Escolar D; Brockington M; Clement EM; Mein R; Jimenez-Mallebrera C; Torelli S; Feng L; Brown SC; Sewry CA; Rutherford M; Shapira Y; Abbs S; Muntoni F
    Ann Neurol; 2006 Nov; 60(5):603-610. PubMed ID: 17044012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome.
    Bobadilla-Quesada EJ; Natera-de Benito D; Carrera-García L; Ortez C; Exposito-Escudero J; Jimenez-Mallebrera C; Jou C; Codina A; Corbera J; Moya O; Saez V; Gonzalez-Quereda L; Gallano P; Colomer J; Cuadras D; Medina J; Yoldi ME; Nascimento A
    Neuromuscul Disord; 2020 Sep; 30(9):719-726. PubMed ID: 32819792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
    Martin PT
    Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.
    Bello L; Melacini P; Pezzani R; D'Amico A; Piva L; Leonardi E; Torella A; Soraru G; Palmieri A; Smaniotto G; Gavassini BF; Vianello A; Nigro V; Bertini E; Angelini C; Tosatto SC; Pegoraro E
    Eur J Hum Genet; 2012 Dec; 20(12):1234-9. PubMed ID: 22549409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
    Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
    Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.